Profile data is unavailable for this security.
About the company
GVS SpA is an Italy-based manufacturer of filters and components for applications in the healthcare, life sciences, automotive, appliance, safety, commercial and industrial filtration. Its offering includes seven product lines: Healthcare, Laboratory, Mobility, Air Safety, Appliance, Personal Safety and Membranes. Each product line provides a suite of customizable solutions specifically related to each market. Additionally, the Company offers tailormade product and process development services, which cover all the project stages, including product and process design, validation, up to the mass production for large quantities. It is active globally.
- Revenue in EUR (TTM)433.30m
- Net income in EUR17.36m
- Incorporated1992
- Employees4.39k
- LocationGVS SpAVia Roma, 50ZOLA PREDOSA 40069ItalyITA
- Websitehttps://www.gvs.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
RaySearch Laboratories AB (publ) | 101.40m | 15.19m | 461.96m | 414.00 | 40.26 | 8.69 | 12.79 | 4.56 | 5.10 | 5.10 | 34.09 | 23.65 | 0.6023 | 5.51 | 3.29 | 3,005,152.00 | 9.02 | 1.29 | 13.69 | 1.88 | 91.06 | 90.57 | 14.97 | 2.55 | 1.27 | 108.61 | 0.3706 | 69.00 | 21.16 | 10.26 | 243.06 | 0.7648 | -1.31 | -- |
Advanced Medical Solutions Group plc | 157.04m | 13.33m | 546.50m | 1.50k | 41.17 | 1.88 | 20.31 | 3.48 | 0.051 | 0.051 | 0.6011 | 1.12 | 0.3977 | 1.70 | 4.91 | 154,244.70 | 3.38 | 6.54 | 3.64 | 7.06 | 54.45 | 56.75 | 8.49 | 14.82 | 6.80 | -- | 0.2702 | 25.85 | 1.51 | 4.23 | -22.14 | -6.71 | 15.66 | 12.32 |
Surgical Science Sweden AB | 74.58m | 16.77m | 644.51m | 270.00 | 39.20 | 1.70 | 29.52 | 8.64 | 3.79 | 3.79 | 16.85 | 87.19 | 0.1769 | 1.56 | 6.80 | 3,307,035.00 | 3.98 | 4.49 | 4.21 | 4.78 | 68.65 | 70.06 | 22.49 | 23.75 | 3.73 | -- | 0.00 | 0.00 | 10.01 | 68.14 | 24.47 | -- | 38.57 | -- |
Revenio Group Oyj | 102.08m | 19.01m | 724.26m | 230.00 | 37.48 | 7.10 | 29.86 | 7.10 | 0.7204 | 0.7204 | 3.86 | 3.81 | 0.7834 | 4.93 | 8.17 | 472,574.10 | 14.67 | 14.33 | 17.09 | 17.90 | 49.29 | 50.73 | 18.72 | 21.13 | 1.51 | 34.57 | 0.1276 | 55.81 | -0.4125 | 25.80 | -12.15 | 18.72 | 17.67 | 6.30 |
Arjo AB (publ) | 969.97m | 44.33m | 729.04m | 6.85k | 18.17 | 1.18 | 5.61 | 0.7516 | 1.88 | 1.88 | 41.05 | 28.87 | 0.7149 | 4.54 | 6.78 | 1,644,896.00 | 3.26 | 3.55 | 4.62 | 5.55 | 43.64 | 44.01 | 4.56 | 5.41 | 0.626 | 3.97 | 0.4073 | 43.01 | 10.03 | 5.97 | 6.90 | 10.15 | -8.89 | 10.35 |
Paul Hartmann AG | 2.38bn | 59.53m | 741.16m | 10.05k | 12.53 | 0.6599 | 4.41 | 0.311 | 16.76 | 16.76 | 671.22 | 318.25 | 1.18 | 1.99 | 5.45 | 234,407.10 | 3.19 | 3.87 | 4.19 | 5.34 | 58.00 | 56.71 | 2.70 | 2.98 | 1.31 | 7.68 | 0.2082 | 42.75 | 1.80 | 2.12 | -21.37 | -18.49 | 5.95 | 2.71 |
Medartis Holding AG | 236.86m | 4.34m | 748.65m | 829.00 | 173.58 | 2.67 | 27.21 | 3.16 | 0.3088 | 0.3088 | 17.04 | 20.07 | 0.5377 | 0.5674 | 4.96 | 265,720.50 | 0.9845 | 0.1919 | 1.13 | 0.2153 | 80.53 | 82.33 | 1.83 | 0.3542 | 3.15 | 4.03 | 0.3227 | 0.00 | 15.96 | 11.81 | 110.70 | -31.82 | 5.37 | -- |
Draegerwerk AG & Co KGaA | 3.35bn | 113.44m | 800.33m | 16.56k | 6.88 | 0.5441 | 3.10 | 0.2391 | 6.05 | 6.05 | 178.45 | 76.45 | 1.11 | 2.47 | 4.97 | 205,014.40 | 3.80 | 3.26 | 5.61 | 4.87 | 43.51 | 44.16 | 3.41 | 3.05 | 1.10 | 6.83 | 0.1704 | 11.38 | 10.78 | 5.39 | 271.05 | 33.87 | 2.64 | 55.73 |
GVS SpA | 433.30m | 17.36m | 907.85m | 4.39k | 52.25 | 2.60 | 14.58 | 2.10 | 0.1001 | 0.1001 | 2.48 | 2.01 | 0.4522 | 2.13 | 6.97 | 98,792.30 | 1.81 | 7.35 | 2.30 | 10.82 | 55.35 | 58.74 | 4.00 | 12.44 | 0.9776 | 3.51 | 0.5369 | -- | 9.58 | 15.25 | -43.37 | -9.97 | 16.08 | -- |
El En SpA | 659.63m | 49.76m | 979.76m | 2.11k | 19.17 | 2.66 | 15.64 | 1.49 | 0.6223 | 0.6223 | 8.25 | 4.49 | 0.9141 | 1.77 | 3.69 | 316,823.50 | 7.02 | 7.43 | 12.89 | 13.52 | 40.03 | 38.83 | 7.68 | 7.63 | 1.19 | -- | 0.1845 | -- | 2.78 | 14.88 | -12.47 | 23.49 | -13.40 | -- |
Biotage AB | 184.50m | 22.29m | 1.07bn | 675.00 | 48.45 | 3.27 | 28.23 | 5.81 | 3.21 | 3.21 | 26.56 | 47.60 | 0.4312 | 1.59 | 7.22 | 3,155,786.00 | 5.21 | 10.74 | 6.05 | 12.77 | 62.67 | 61.40 | 12.08 | 15.75 | 1.15 | 43.88 | 0.0616 | 40.11 | 19.54 | 15.50 | -8.21 | 7.97 | 14.05 | 1.30 |
ChemoMetec A/S | 54.69m | 18.27m | 1.11bn | 173.00 | 62.03 | 14.95 | 53.66 | 20.26 | 7.83 | 7.83 | 23.44 | 32.48 | 0.6112 | 0.745 | 6.97 | 2,357,630.00 | 20.42 | 27.96 | 24.40 | 35.10 | 78.80 | 79.57 | 33.41 | 35.02 | 3.76 | -- | 0.0073 | 144.08 | -8.22 | 18.37 | -23.72 | 26.64 | 9.97 | -11.81 |
Xvivo Perfusion AB | 65.11m | 17.72m | 1.23bn | 161.00 | 70.60 | 7.02 | 51.36 | 18.88 | 6.58 | 6.58 | 24.07 | 66.13 | 0.3325 | 1.14 | 4.67 | 4,691,194.00 | 9.05 | 1.24 | 9.68 | 1.33 | 74.41 | 73.14 | 27.21 | 4.76 | 4.23 | -- | 0.0117 | 0.00 | 43.88 | 26.04 | 398.29 | 48.57 | 21.35 | -- |
AddLife AB | 868.48m | 10.15m | 1.34bn | 2.36k | 138.53 | 3.16 | 14.78 | 1.55 | 0.9601 | 0.9601 | 82.16 | 42.09 | 0.7625 | 3.50 | 5.58 | 4,351,152.00 | 0.9063 | 5.31 | 1.29 | 8.83 | 37.30 | 36.89 | 1.19 | 5.79 | 0.638 | 1.66 | 0.5146 | 31.73 | 6.62 | 31.30 | -60.42 | 8.00 | 44.43 | -1.89 |
Data as of Nov 25 2024. Currency figures normalised to GVS SpA's reporting currency: Euro EUR
Holder | Shares | % Held |
---|---|---|
Capital Research & Management Co. (World Investors)as of 30 Sep 2024 | 7.86m | 4.49% |
Mediolanum Gestione Fondi SGRpAas of 28 Jun 2024 | 3.21m | 1.83% |
T. Rowe Price International Ltd.as of 30 Sep 2024 | 2.70m | 1.54% |
The Vanguard Group, Inc.as of 06 Nov 2024 | 2.48m | 1.42% |
Amundi Asset Management SA (Investment Management)as of 06 Nov 2024 | 2.09m | 1.19% |
Invesco Asset Management Ltd.as of 30 Sep 2024 | 1.81m | 1.04% |
Degroof Petercam Asset Management SAas of 31 Jul 2024 | 1.79m | 1.02% |
Fidelity Management & Research Co. LLCas of 30 Sep 2024 | 1.76m | 1.01% |
Fideuram Asset Management SGR SpAas of 31 Oct 2024 | 1.66m | 0.95% |
Joh. Berenberg, Gossler & Co. KG (Investment Management)as of 29 Sep 2023 | 1.43m | 0.81% |
More ▼
Data from 28 Jun 2024 - 20 Nov 2024Source: FactSet Research Systems Inc.